The ability of GPER-1 to modulate key signaling pathways, influence gene expression, and participate in specific molecular cascades in nervous and reproductive tissue is a developing area but represents a significant advance toward a greater understanding of the pathophysiology of breast cancer and other chronic nerve and metabolic diseases. The gene discussed is GPER1; the disease is breast carcinoma.